tiprankstipranks
Trending News
More News >
CTS Corporation (CTS)
:CTS
Advertisement

CTS (CTS) AI Stock Analysis

Compare
125 Followers

Top Page

CTS

CTS

(NYSE:CTS)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
$44.00
▲(6.54% Upside)
CTS's overall stock score reflects a stable financial foundation with strong profitability and low leverage. The earnings call provided positive insights into growth in diversified markets and strategic wins, which bolster the company's outlook. However, the valuation is moderate, and technical indicators suggest caution due to potential overbought conditions.

CTS (CTS) vs. SPDR S&P 500 ETF (SPY)

CTS Business Overview & Revenue Model

Company DescriptionCTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company provides sensors and actuators for use in passenger or commercial vehicles; connectivity components for telecommunications infrastructure, information technology, and other high-speed applications; switches, temperature sensors, and potentiometers supplied to multiple markets; and fabricated piezoelectric materials and substrates used primarily in medical, industrial, aerospace and defense, and information technology markets. In addition, the company sells and markets its products through its sales engineers, independent manufacturers' representatives, and distributors. CTS Corporation was founded in 1896 and is headquartered in Lisle, Illinois.
How the Company Makes MoneyCTS generates revenue through the sale of its electronic components and sensors to a wide array of industries. The company's key revenue streams include the production of sensors and actuators for aerospace and defense applications, as well as electronic components for industrial and medical devices. Additionally, CTS benefits from long-term relationships with major clients and strategic partnerships that enhance its market presence and drive sales. Their focus on innovation and the development of advanced technologies also contributes to increased demand for their products, further solidifying their revenue model.

CTS Earnings Call Summary

Earnings Call Date:Oct 28, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 10, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong growth in diversified end markets and new contract wins, particularly in the industrial and aerospace sectors. However, there were challenges, including a decline in transportation sales and adverse impacts from tax legislation. Despite these issues, the company showed resilience with strategic wins and a solid financial outlook.
Q3-2025 Updates
Positive Updates
Diversified End Markets Growth
Sales in diversified end markets, including medical, aerospace and defense, and industrial, increased by 22% year-over-year, making up 59% of the total company revenue.
SyQwest Naval Defense Contract
SyQwest was awarded a sole-source naval defense contract with an initial value of $5 million, with potential additional platform awards within the next 12 months.
Strong Industrial Market Performance
Industrial market sales increased 9% sequentially and 21% year-over-year, with bookings up 29% from the same period last year.
Aerospace and Defense Sales Increase
Aerospace and defense sales grew by 23% compared to the third quarter of 2024, with SyQwest revenues at $8.8 million.
Negative Updates
Decline in Transportation Sales
Transportation sales were down 7% from the same period last year, primarily due to softness in commercial vehicle products.
Adverse Impact from U.S. Tax Legislation
Adjusted diluted earnings per share decreased from $0.61 in Q3 2024 to $0.60 in Q3 2025, primarily due to an unfavorable impact from recent U.S. tax legislation changes.
Lower Operating Cash Flow
Operating cash flow in Q3 was $29 million, down from $35 million in Q3 2024.
Company Guidance
In the third quarter of 2025, CTS Corporation reported notable financial metrics and strategic advancements. The company achieved sales of $143 million, marking an 8% increase from the prior year, with diversified end market sales soaring by 22%. However, transportation sales saw a 7% decline, primarily due to softness in commercial vehicle products. The gross margin improved by 66 basis points year-over-year, reaching 38.9%, while adjusted EBITDA was 23.8%. Despite facing unfavorable impacts from recent U.S. tax legislation, adjusted diluted earnings per share were $0.60. The company narrowed its full-year guidance, projecting sales between $535 million and $545 million and adjusted diluted EPS ranging from $2.20 to $2.25. Additionally, CTS highlighted significant contract wins, including a $5 million naval defense contract for SyQwest, and achieved a book-to-bill ratio slightly above 1. The company emphasized continued diversification and growth in medical, aerospace, and industrial markets, alongside strategic acquisitions and strong cash generation, with a current cash balance of $110 million and $73 million generated in operating cash flow year-to-date.

CTS Financial Statement Overview

Summary
CTS demonstrates a stable financial position with strong profitability and low leverage. While revenue and cash flow growth are areas to watch, the company maintains healthy margins and a solid balance sheet, positioning it well for future opportunities.
Income Statement
75
Positive
CTS shows a solid performance with a consistent gross profit margin of around 38% in the TTM, indicating effective cost management. The net profit margin is stable at approximately 11%, reflecting good profitability. Revenue growth is modest at 2.02% in the TTM, suggesting steady but slow growth. The EBIT and EBITDA margins are healthy, supporting operational efficiency.
Balance Sheet
70
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.13 in the TTM, indicating low leverage and financial stability. Return on equity is moderate at 8.79%, showing decent returns for shareholders. However, the equity ratio is not provided, which limits a full assessment of asset financing.
Cash Flow
65
Positive
Cash flow analysis reveals a slight decline in free cash flow growth by -8.34% in the TTM, which could be a concern if the trend continues. The operating cash flow to net income ratio is slightly above 1, indicating good cash generation relative to net income. The free cash flow to net income ratio is strong at 0.83, showing efficient cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue531.63M515.54M550.55M586.87M512.92M424.19M
Gross Profit202.55M188.21M188.19M209.61M183.24M139.94M
EBITDA115.91M108.17M109.50M113.22M-32.58M74.99M
Net Income59.19M58.11M60.53M59.58M-41.87M34.69M
Balance Sheet
Total Assets790.37M766.11M741.17M748.49M664.46M626.05M
Cash, Cash Equivalents and Short-Term Investments110.30M94.33M163.88M156.91M141.47M91.77M
Total Debt132.56M117.09M96.86M109.36M74.75M81.06M
Total Liabilities242.72M235.26M214.34M242.26M200.88M202.37M
Stockholders Equity547.65M530.85M526.82M506.22M463.58M423.68M
Cash Flow
Free Cash Flow80.20M80.64M74.07M106.86M70.50M61.92M
Operating Cash Flow98.85M99.29M88.81M121.20M86.14M76.78M
Investing Cash Flow-18.64M-140.56M-18.10M-111.19M-15.90M-23.17M
Financing Cash Flow-67.84M-27.93M-65.40M4.34M-20.71M-61.33M

CTS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price41.30
Price Trends
50DMA
40.86
Positive
100DMA
41.21
Negative
200DMA
41.85
Negative
Market Momentum
MACD
0.45
Negative
RSI
50.16
Neutral
STOCH
83.35
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTS, the sentiment is Negative. The current price of 41.3 is above the 20-day moving average (MA) of 40.71, above the 50-day MA of 40.86, and below the 200-day MA of 41.85, indicating a neutral trend. The MACD of 0.45 indicates Negative momentum. The RSI at 50.16 is Neutral, neither overbought nor oversold. The STOCH value of 83.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CTS.

CTS Risk Analysis

CTS disclosed 38 risk factors in its most recent earnings report. CTS reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CTS Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$1.91B29.7816.40%0.18%23.70%14.78%
69
Neutral
$1.54B41.013.37%1.50%-2.93%-40.33%
68
Neutral
$1.26B21.9910.98%0.37%3.70%1.68%
67
Neutral
$942.46M4,486.364.36%-7.67%7.66%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
$1.48B-22.69-5.34%-4.87%-235.48%
54
Neutral
$232.79M-7.62%5.89%-4.91%61.77%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CTS
CTS
41.01
-16.75
-29.00%
BELFB
Bel Fuse Inc
160.16
78.63
96.44%
BHE
Benchmark Electronics
45.37
-5.59
-10.97%
DAKT
Daktronics
19.25
4.32
28.94%
MEI
Methode Electronics
6.50
-2.98
-31.43%
ROG
Rogers
84.45
-24.46
-22.46%

CTS Corporate Events

CTS Corporation Reports Strong Q3 2025 Performance
Oct 29, 2025

CTS Corporation is a global leader in designing and manufacturing custom-engineered solutions that ‘Sense, Connect and Move,’ serving diverse markets such as aerospace, defense, industrial, medical, and transportation.

CTS Corp’s Earnings Call: Growth Amid Challenges
Oct 29, 2025

CTS Corporation’s recent earnings call painted a picture of robust growth and strategic resilience, despite facing some headwinds. The company reported strong performance in diversified end markets and celebrated new contract wins, notably in the industrial and aerospace sectors. However, challenges such as a decline in transportation sales and adverse effects from tax legislation were also highlighted. Overall, the sentiment was positive, underscoring CTS’s strategic wins and a solid financial outlook.

Business Operations and StrategyM&A Transactions
CTS Corporation Highlights Strategic Growth Initiatives
Positive
Oct 28, 2025

In its recent investor presentation, CTS Corporation highlighted its strategic focus on growth and diversification across various end markets, aiming for a 10% organic and inorganic growth. The company emphasized its strong balance sheet and cash flow to support mergers and acquisitions, alongside a robust new product pipeline driven by megatrends such as automation, healthcare innovation, and electrification. CTS is leveraging its deep technical expertise and global footprint to enhance operational excellence and drive profitable growth, positioning itself to capitalize on market opportunities and address key challenges in its industry.

The most recent analyst rating on (CTS) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on CTS stock, see the CTS Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
CTS Corporation Reports Strong Q3 2025 Financial Results
Positive
Oct 28, 2025

CTS Corporation announced its third quarter 2025 financial results, reporting a strong 22% year-over-year sales growth in diversified end markets despite a 7% decline in the transportation sector. The company achieved $143 million in sales, with a net income of $14 million, impacted by a $4.2 million charge related to an EPA claim. Adjusted gross margin improved slightly to 38.9%, while operating cash flow decreased to $29 million from the previous year. CTS updated its 2025 guidance, projecting sales between $535-$545 million and adjusted diluted EPS of $2.20-$2.25, reflecting its strategic focus on diversification and margin expansion.

The most recent analyst rating on (CTS) stock is a Buy with a $44.00 price target. To see the full list of analyst forecasts on CTS stock, see the CTS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025